Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy [Phase 2]
Phase 2 trial investigating nivolumab with chemoradiotherapy for muscle-invasive bladder cancer in patients not undergoing cystectomy.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating durvalumab for non-muscle-invasive bladder cancer is underway; full results are not yet available.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer [Phase 2]
Phase II study evaluating TAS-102 (Lonsurf) in metastatic bladder cancer resistant to platinum therapy and checkpoint inhibitors.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating eribulin mesylate in combination with gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) [Phase 3]
Phase 3 trial evaluating immediate postoperative intravesical instillation with either gemcitabine or epirubicin for bladder cancer; current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cytokine-induced killer cells for metastatic urogenital tumors (bladder and renal cancer) is ongoing b…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial of nab-paclitaxel plus gemcitabine as first-line therapy for cisplatin-ineligible or cisplatin-incurable advanced urothelial c…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer [Phase 2]
Phase 2 SWOG S1314 COXEN program completed to predict chemotherapy response in bladder cancer; results were posted in January 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of enfortumab vedotin in locally advanced or metastatic urothelial cancer has been completed and results have been posted. The…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer [Phase 3]
Phase 3 trial evaluating adjuvant nivolumab vs placebo after surgical resection for bladder cancer and upper tract urothelial carcinoma, wit…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer [Phase 3]
Phase 3 trial evaluating nivolumab versus placebo after surgery in bladder or upper urinary tract cancer; results completed with posted data…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract [Phase 2]
Phase 2 trial evaluating durvalumab with tremelimumab for metastatic non-transitional cell carcinoma of the urothelial tract shows completed…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention [Phase 1, Phase 2]
Phase 1/2 clinical trial update for an intravesical antifibrinolytic aimed at patients with hematuria and clot retention.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. [Phase 2]
Phase 2 clinical trial update on tisotumab vedotin with continued treatment in patients with various solid tumors, including gynecologic and…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable [Phase 2]
Phase 2 clinical trial evaluating tilelizumab with nab-paclitaxel for high-risk non-muscle-invasive urothelial bladder carcinoma that is not…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 safety study of recombinant human hyaluronidase (Chemophase) with mitomycin in superficial bladder cancer has completed; results…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants [Phase 1, Phase 2]
This clinical trial update reports safety and pharmacology results for atezolizumab alone and with BCG in high-risk non-muscle-invasive blad…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) [Phase 3]
Phase 3 trial of intravesical apaziquone (Qapzola) as a surgical adjuvant during TURBT for bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) [Phase 3]
Phase 3 trial of intravesical apaziquone as a surgical adjuvant in TURBT for bladder cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer [Phase 1]
Phase Ib feasibility neoadjuvant trial of nivolumab plus lirilumab for cisplatin-ineligible muscle-invasive bladder cancer has completed enr…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) [Phase 3]
Phase 3 EV-301 trial comparing enfortumab vedotin to standard chemotherapy in previously treated locally advanced or metastatic urothelial c…